Johnson & Johnson guides to 8.2% adjusted EPS growth at its 2026 midpoint, compared with approximately 7% implied by 2026 ...

The Company remains on track to complete 12-month visits by early Q2 2027. Envoy Medical has submitted two of the four ...

Larger Human-Submitted Dataset Now Ready for Public Technical Update as Testing Continues MESA, AZ / ACCESS Newswire / October 20, 2026 / Medical Care Technologies Inc. (OTCID:MDCE) today announced th ...

EXPRESS Phase 2 design finalized: 52 weeks of dosing of approximately 60 patients randomized 1:1 to exaluren or placebo, with ...

Larger Human-Submitted Dataset Now Ready for Public Technical Update as Testing Continues MESA, AZ / ACCESS Newswire / ...

EXPRESS Phase 2 design finalized: 52 weeks of dosing of approximately 60 patients randomized 1:1 to exaluren or placebo, with annualized htTKV growth as the primary ...

Nobel-winning scientific breakthroughs have repeatedly emerged from organisms once considered too simple or too distant from human biology to be useful. Research on yeast revealed fundamental ...

Anteris Technologies Global Corp. ('Anteris” or the 'Company”) (NASDAQ: AVR, ASX: AVR) announced today that it has received full regulatory clearance from the German Federal Institute for Drugs and ...

Doctors at Mumbai’s Wadia Hospital successfully treated a newborn girl diagnosed with Cantrell’s Pentalogy, a rare congenital ...

Baird Medical Investment Holdings Limited (NASDAQ:BDMD) announced on 19 October 2026 that it had obtained additional medical device registrations in Vietnam and received preliminary regulatory ...

Medical researchers reported remarkable progress in 2026, introducing new treatments and technologies that could transform ...

Back in August, the agency outlined plans to grant faster coverage for “breakthrough” devices in radiology and other ...